According to a new study, patients who take Frovatripan and a daily dose of Topamax can reduce the number of migraines they have. When it comes to treating migraines, the type of migraines the patient suffers plays a role in choosing the medication, and this study shows that while Topamax is better at preventing prophylactic migraines, Frovatripan works best for treating acute migraines.
Topamax is widely considered to be one of the most effective migraine prophylactic medications on the market. Frovatriptan is used as a treatment for acute migraines, as well as a short-term prophylactic medication for treating menstrual migraines. While the Frovatriptan is approved for treating acute migraines, Topamax is best used as a treatment for migraine prophylaxis.
This pilot study, as published on Medscape, reports that “in selected patients with predictable migraine attacks associated with premonitory symptoms, the paradigm of pre-emptive prophylaxis using Frovatriptan intermittently during the premonitory period reduced frequency of migraine attacks and headache days comparable with that achieved with daily use of topamirate. Frovatriptan was well-tolerated when used in this treatment paradigm.”
Using Topamax as a migraine medication is nothing new, and the drug is often prescribed for this purpose. However, the drug has also been linked to various adverse side effects, including birth defects in babies whose mothers take the drug while pregnant. Some of those birth defects include PPHN, oral clefts, cleft palate, spina bifida and neural defects. It is for this reason that female migraine sufferers of childbearing age may want to avoid Topamax as a migraine treatment.
If your child was born with birth defects and you have taken Topamax, contact attorney Greg Jones today for a free consultation. I am experienced at fighting Topamax lawsuits and may be able to help you recover money for your child’s injuries.
About Greg Jones Law
You May Also Like